As a market,
bionanotechnology is projected to grow world-wide by a rate of 28%. No further explanation is needed why the
field is increasingly considered “the future of everything,” even if its
potential for raising concerns is seldom overlooked and no FDA
regulations exist to date.
As one can always
safely assume with interdisciplinary areas, the father of all things is a
dispute over terminology – in this case, the distinction, if any, between
nanobiotechnology and bionanotechnology. Although enough ink is being spilled
on that, it hardly matters: if nanobiotechnology, as a Lilliput version of
biotechnology, takes concepts and fundamentals directly from nanotechnology to
biotechnological use, bionanotechnology derives its concepts from mechanics,
electricity, electronics, optics, and biology, and relates structural and mechanistic
analysis of molecular-level biological
processes into specific synthetic applications of nanotechnology. Not a
distinction without a difference, but it matters little due to one principal
characteristic of all nanotechnology: at the molecular and submolecular scale, biochemistry,
biophysics, biology, and all other forms of human inquiry converge. Thus, multidisciplinarity is inherent.